2014 annual financial data
Relmada Therapeutics 2014 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -17,099,280 USD and net income was -20,803,596 USD.
Operating cash flow was -16,226,728 USD.
Get free Relmada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -17,099,280 USD
- Net income
- -20,803,596 USD
- Operating cash flow
- -16,226,728 USD